By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AnTolRx, Inc. 

One Kendall Square
Building 1400 West, Suite 14303
Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-945-8468 Fax: n/a


SEARCH JOBS

At AnTolRx, we are approaching the treatment of autoimmune diseases differently–through the development of novel nanoparticle-based therapies to promote antigen-specific immune tolerance. Standard therapies broadly suppress the immune system, inducing side effects that may include life threatening infections and tumors. Thus, there is an unmet clinical need for methods of targeted immune-regulation. Our proprietary drug development approach selectively targets pathogenic immune cells providing a unique tolerogenic signal to induce an anti-inflammatory phenotype and better treat diseases.

YEAR FOUNDED:

2016

LEADERSHIP:

Founder and CEO: Mark Carthy

Scientific Founder: Francisco J Quintana, PhD

Member BoD: Satish Jindal, PhD

Scientific Consultant: Vincent Stanton Jr.

Senior Scientist: Jessica Kenison-White

CLINICAL

Please click here for AnTolRx's Pipeline.


Key Statistics


Email: jessica.kenison@antolrx.com
Ownership: Private

Web Site: AnTolRx
Employees:
Symbol: 
 









Company News
//-->